We are international
Donate
TEXT SIZE   


Dr. Richardson - A Phase I Study of Vorinostat, Lenalidomide, and Dexamethasone In Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Excellent Tolerability and Promising Activity In a Heavily Pretreated Population
Paul G. Richardson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
USA
12.02.10


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles